2 months ago
ROIV
AnalystsYatin SunejaYatin Suneja's Stock Forecasts
AnalystsYatin Suneja
Analyst Ranking
Top 3%
#160 out of 5548 analysts
Average Return
+21.71%
Win Rate
52%108 out of 207
Risk vs Reward
Poor
Good
Yatin Suneja's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Forte Biosciences IncFBRX | +545.59% | $11.91 | $76.89 | 2025-08-18 - 2026-08-17 | Strong Buy |
Alumis IncALMS | +495.54% | $3.36 | $20.01 | 2025-06-10 - 2026-06-09 | Strong Buy |
Reata Pharmaceuticals IncRETA | +376.00% | $36.21 | $172.36 | 2022-10-19 - 2023-09-25 | Strong Buy |
Phathom Pharmaceuticals IncPHAT | +335.14% | $2.76 | $12.01 | 2025-05-02 - 2026-05-01 | Strong Buy |
Zura Bio LtdZURA | +320.97% | $1.34 | $5.62 | 2025-03-26 - 2026-03-25 | Strong Buy |
Yatin Suneja Analyst Color
Get additional color on Yatin Suneja's coverage of popular stocks
2 months ago
PMN
2 months ago
ZURA
2 months ago
AXSM
3 months ago
SYRE
3 months ago
NBIX
3 months ago
ARGX
3 months ago
CLDX
5 months ago
ALMS
6 months ago
AXSM
7 months ago
ORKA
7 months ago
AXSM
7 months ago
CABA
7 months ago
ZBIO
8 months ago
DNTH
8 months ago
PHAT
8 months ago
PRAX
10 months ago
ALMS
10 months ago
DBVT
a year ago
PRAX
a year ago
IFRX
a year ago
PRAX
a year ago
ABVX
a year ago
ACET
a year ago
ROIV
Yatin Suneja's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Argenx SeARGX | 16 | Strong Buy | $1,120.00 | +28.19% | Maintains | 2 days ago |
Avalo Therapeutics IncAVTX | 3 | Hold | N/A | N/A | Downgrades | 2 days ago |
Abivax SaABVX | 4 | Strong Buy | $175.00 | +98.84% | Reiterates | 5 days ago |
Eyepoint IncEYPT | 4 | Hold | N/A | N/A | Downgrades | 5 days ago |
Korsana Biosciences IncKRSA | 1 | Strong Buy | $70.00 | +123.57% | Initiates Coverage On | a month ago |
First Tracks Biotherapeutics IncTRAX | 1 | Strong Buy | $100.00 | +127.01% | Initiates Coverage On | a month ago |
Roivant Sciences LtdROIV | 7 | Strong Buy | $46.00 | +26.06% | Maintains | 2 months ago |
Alumis IncALMS | 5 | Hold | N/A | N/A | Downgrades | 2 months ago |
Latigo Biotherapeutics IncLTGO | 1 | Strong Buy | $50.00 | +232.89% | Initiates Coverage On | 2 months ago |
Zenas Biopharma IncZBIO | 5 | Strong Buy | $55.00 | +104.69% | Reiterates | 2 months ago |
Promis Neurosciences IncPMN | 1 | Strong Buy | $100.00 | +1,099.04% | Maintains | 2 months ago |
Zura Bio LtdZURA | 3 | Strong Buy | $20.00 | +495.24% | Maintains | 2 months ago |
Oruka Therapeutics IncORKA | 6 | Strong Buy | $200.00 | +149.53% | Reiterates | 2 months ago |
Axsome Therapeutics IncAXSM | 12 | Strong Buy | $275.00 | +89.60% | Maintains | 2 months ago |
Sionna Therapeutics IncSION | 3 | Hold | N/A | N/A | Downgrades | 2 months ago |
Adicet Bio IncACET | 5 | Strong Buy | $90.00 | +2,155.64% | Maintains | 3 months ago |
Spyre Therapeutics IncSYRE | 2 | Strong Buy | $130.00 | +43.92% | Maintains | 3 months ago |
Stoke Therapeutics IncSTOK | 1 | Strong Buy | $60.00 | +139.62% | Reiterates | 3 months ago |
Phathom Pharmaceuticals IncPHAT | 6 | Strong Buy | $22.00 | +283.28% | Maintains | 3 months ago |
Neurocrine Biosciences IncNBIX | 8 | Strong Buy | $222.00 | +55.57% | Maintains | 3 months ago |
Celldex Therapeutics IncCLDX | 5 | Strong Buy | $100.00 | +241.88% | Maintains | 3 months ago |
Climb Bio IncCLYM | 3 | Strong Buy | $35.00 | +243.47% | Initiates Coverage On | 5 months ago |
Oculis Holding AgOCS | 2 | Strong Buy | $45.00 | +469.62% | Maintains | 5 months ago |
Immunovant IncIMVT | 10 | Strong Buy | $62.00 | +118.23% | Maintains | 5 months ago |
Dbv Technologies SaDBVT | 4 | Strong Buy | $51.00 | +423.08% | Reiterates | 6 months ago |
Regeneron Pharmaceuticals IncREGN | 10 | Strong Buy | $995.00 | +23.60% | Maintains | 6 months ago |
Biogen IncBIIB | 5 | Strong Buy | $260.00 | +3.71% | Maintains | 6 months ago |
Inflarx NvIFRX | 6 | Strong Buy | $14.00 | +797.44% | Reiterates | 6 months ago |
Neumora Therapeutics IncNMRA | 4 | Strong Buy | $14.00 | +3,593.93% | Reiterates | 7 months ago |
Cabaletta Bio IncCABA | 7 | Strong Buy | $16.00 | +988.44% | Maintains | 7 months ago |
Immunic IncIMUX | 1 | Strong Buy | $70.00 | +844.67% | Initiates Coverage On | 7 months ago |
Dianthus Therapeutics IncDNTH | 3 | Strong Buy | $200.00 | +160.48% | Maintains | 8 months ago |
Praxis Precision Medicines IncPRAX | 5 | Strong Buy | $800.00 | +216.26% | Maintains | 8 months ago |
Sab Biotherapeutics IncSABS | 1 | Strong Buy | $15.00 | +428.17% | Initiates Coverage On | 10 months ago |
Anaptysbio IncANAB | 10 | Strong Buy | $100.00 | +105.21% | Maintains | a year ago |
Rapt Therapeutics IncRAPT | 4 | Strong Buy | $70.00 | +20.65% | Initiates Coverage On | a year ago |
Moonlake ImmunotherapeuticsMLTX | 4 | Strong Buy | $20.00 | N/A | Maintains | a year ago |
Tourmaline Bio IncTRML | 4 | Hold | $48.00 | N/A | Downgrades | a year ago |
Forte Biosciences IncFBRX | 1 | Strong Buy | $75.00 | N/A | Initiates Coverage On | a year ago |
Larimar Therapeutics IncLRMR | 6 | Strong Buy | $26.00 | N/A | Reiterates | a year ago |
Gh Research PLCGHRS | 1 | Strong Buy | $29.00 | N/A | Maintains | a year ago |
Vigil Neuroscience IncVIGL | 3 | Strong Buy | N/A | N/A | Reiterates | 2 years ago |
Surrozen IncSRZN | 3 | Strong Buy | $45.00 | N/A | Upgrades | 2 years ago |
Q32 Bio IncQTTB | 2 | Hold | N/A | N/A | Downgrades | 2 years ago |
Longboard Pharmaceuticals IncLBPH | 3 | Strong Buy | $32.00 | N/A | Maintains | 3 years ago |
Karuna Therapeutics IncKRTX | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Bioxcel Therapeutics IncBTAIQ | 3 | Hold | N/A | N/A | Downgrades | 3 years ago |
Xenon Pharmaceuticals IncXENE | 2 | Strong Buy | $49.00 | N/A | Reiterates | 3 years ago |
Prometheus Biosciences IncRXDX | 3 | Hold | $200.00 | N/A | Downgrades | 4 years ago |
Acadia Pharmaceuticals IncACAD | 5 | Strong Buy | $22.00 | N/A | Upgrades | 4 years ago |
Sage Therapeutics IncSAGE | 4 | Hold | N/A | N/A | Downgrades | 4 years ago |
Horizon Therapeutics Public Ltd CoHZNP | 1 | Hold | $116.50 | N/A | Downgrades | 4 years ago |
Reata Pharmaceuticals IncRETA | 1 | Strong Buy | $75.00 | N/A | Initiates Coverage On | 4 years ago |
Relmada Therapeutics IncRLMD | 3 | Hold | N/A | N/A | Downgrades | 4 years ago |
Bausch & Lomb CorpBLCO | 1 | Strong Buy | $24.00 | N/A | Initiates Coverage On | 4 years ago |
Seelos Therapeutics IncSEELQ | 1 | Strong Buy | $30,720.00 | N/A | Initiates Coverage On | 5 years ago |
Global Blood Therapeutics IncGBT | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 8 years ago |
Seagen IncSGEN | 1 | Strong Buy | $80.00 | N/A | Upgrades | 8 years ago |
Verona Pharma PLCVRNA | 1 | Strong Buy | $26.00 | N/A | Initiates Coverage On | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.